These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9019813)

  • 1. Biologists mobilize against anti-genetics referendum.
    Koenig R
    Science; 1997 Jan; 275(5300):607-8. PubMed ID: 9019813
    [No Abstract]   [Full Text] [Related]  

  • 2. Who's afraid of biotechnology?
    Tait J
    New Sci; 1992 Jun; 134(1827):49. PubMed ID: 16044585
    [No Abstract]   [Full Text] [Related]  

  • 3. The Swiss vote on gene technology.
    Schatz G
    Science; 1998 Sep; 281(5384):1810-1. PubMed ID: 9776684
    [No Abstract]   [Full Text] [Related]  

  • 4. Voters reject antigenetics initiative.
    Koenig R
    Science; 1998 Jun; 280(5370):1685. PubMed ID: 9660703
    [No Abstract]   [Full Text] [Related]  

  • 5. Swiss researchers facing 'anti-transgenics' vote.
    Schiermeier Q
    Nature; 1997 Jul; 388(6640):315. PubMed ID: 9237739
    [No Abstract]   [Full Text] [Related]  

  • 6. Switzerland. Compromise allows transgenic trials.
    Ku M
    Science; 2002 Oct; 298(5592):343. PubMed ID: 12376677
    [No Abstract]   [Full Text] [Related]  

  • 7. Russia readies its first gene law.
    Allakhverdov A
    Science; 1995 Jun; 268(5217):1558. PubMed ID: 7777849
    [No Abstract]   [Full Text] [Related]  

  • 8. UK embryo research law 'may need changes'.
    Dickson D
    Nature; 1997 Mar; 386(6621):98. PubMed ID: 9062171
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinton's cloning ban may threaten genetic research.
    Hoyle R
    Nat Biotechnol; 1997 Jul; 15(7):600. PubMed ID: 9219249
    [No Abstract]   [Full Text] [Related]  

  • 10. Risks of animal biotechnology.
    Lancet; 2002 Aug; 360(9334):653. PubMed ID: 12241866
    [No Abstract]   [Full Text] [Related]  

  • 11. Britain opens biotech regulation to greater public involvement.
    Masood E
    Nature; 1999 May; 399(6734):287-8. PubMed ID: 10360555
    [No Abstract]   [Full Text] [Related]  

  • 12. The sanctity of life in a brave new world: a manifesto on biotechnology and human dignity.
    Council for Biotechnology Policy, USA
    Hum Reprod Genet Ethics; 2003; 9(2):36-7. PubMed ID: 14964213
    [No Abstract]   [Full Text] [Related]  

  • 13. Swiss reject curbs on genetic engineering.
    Schiermeier Q
    Nature; 1998 Jun; 393(6685):507. PubMed ID: 9634222
    [No Abstract]   [Full Text] [Related]  

  • 14. Human gene patents: core issues in a multi-layered debate.
    Hoedemaekers R
    Med Health Care Philos; 2001; 4(2):211-21. PubMed ID: 11547507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotech battlelines.
    Käppeli O; Auberson L
    Nature; 1998 Jul; 394(6688):10. PubMed ID: 9665118
    [No Abstract]   [Full Text] [Related]  

  • 16. The Cambridge model: how public oversight of biotech is good for everyone--even business.
    Lipson S
    Genewatch; 2003; 16(5):7-10. PubMed ID: 15025120
    [No Abstract]   [Full Text] [Related]  

  • 17. How not to run a scientifically successful country.
    Nature; 1998 Apr; 392(6678):741. PubMed ID: 11645055
    [No Abstract]   [Full Text] [Related]  

  • 18. Making the world a better place: genes and ethics.
    Crisp R
    Sci Eng Ethics; 1995 Apr; 1(2):101-10. PubMed ID: 11660708
    [No Abstract]   [Full Text] [Related]  

  • 19. Bio-patents, law and ethics. Critical analysis of the EU biotechnology directive.
    Van Overwalle G
    Rev Derecho Genoma Hum; 2003; (19):187-203. PubMed ID: 15032104
    [No Abstract]   [Full Text] [Related]  

  • 20. Knowledge and the governance of biotechnology.
    Doubleday R
    Not Polit; 2001; 17(62):22-33. PubMed ID: 15468484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.